ERBB2 and breast cancer: Third, and most importantly, we now dispose of strong hypothesis-generating data about the beneficial impact of metformin in human epidermal growth factor receptor 2+ (HER2+) BC patients, particularly among those with any C allele of the rs11212617 single-nucleotide variant (SNV, formerly single-nucleotide polymorphism [SNP]).